PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Anixa Biosciences, Inc. (ANIX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US03528H1095

CUSIP

03528H109

Sector

Healthcare

IPO Date

Jan 1, 1987

Highlights

Market Cap

$92.41M

EPS (TTM)

-$0.39

Gross Profit (TTM)

-$15.00K

EBITDA (TTM)

-$10.21M

Year Range

$2.07 - $4.20

Target Price

$8.50

Short %

1.28%

Short Ratio

2.94

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Anixa Biosciences, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
-8.94%
10.30%
ANIX (Anixa Biosciences, Inc.)
Benchmark (^GSPC)

Returns By Period

Anixa Biosciences, Inc. had a return of 23.71% year-to-date (YTD) and -25.65% in the last 12 months. Over the past 10 years, Anixa Biosciences, Inc. had an annualized return of 5.03%, while the S&P 500 had an annualized return of 11.31%, indicating that Anixa Biosciences, Inc. did not perform as well as the benchmark.


ANIX

YTD

23.71%

1M

19.09%

6M

-8.31%

1Y

-25.65%

5Y*

-3.23%

10Y*

5.03%

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of ANIX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202525.00%23.71%
202417.01%-22.91%-10.86%-4.81%-18.18%-9.05%50.23%0.60%-5.69%11.11%-5.71%-29.70%-40.21%
20232.82%1.14%-2.71%-5.12%-25.00%4.58%12.19%2.23%-10.90%-3.36%5.70%16.17%-8.71%
202210.44%-15.24%-1.44%18.61%10.46%-14.76%24.18%9.74%17.99%13.82%-10.00%-15.67%43.10%
202118.89%38.63%-7.51%4.27%-18.65%-2.27%13.92%26.70%-14.82%-0.00%-23.69%-18.41%-3.26%
20208.23%-15.77%-46.82%18.87%20.63%34.21%-9.15%-28.78%22.73%-15.23%28.16%16.29%-6.40%
201930.20%-1.36%-10.67%-7.96%0.24%-12.95%29.20%-15.32%0.72%-3.25%-1.03%-14.36%-16.75%
201858.05%-11.80%16.72%-2.86%-5.63%-13.92%8.58%15.81%21.78%-12.72%-3.21%0.51%66.95%
2017-9.26%-19.39%-24.05%-35.00%-56.92%36.90%-31.30%-15.06%291.95%-22.05%21.95%-5.60%-56.30%
2016-2.33%-21.09%29.74%-6.31%14.89%-3.09%1.27%27.67%-4.19%63.24%-10.24%-5.26%79.40%
2015-2.73%-10.09%37.32%-9.16%8.33%23.08%22.25%-14.31%13.37%-21.68%-24.46%7.12%9.45%
2014108.89%-24.41%0.00%13.33%-13.24%1.69%-13.67%2.70%-9.77%-16.67%-15.00%-35.29%-42.11%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ANIX is 24, meaning it’s performing worse than 76% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ANIX is 2424
Overall Rank
The Sharpe Ratio Rank of ANIX is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of ANIX is 2525
Sortino Ratio Rank
The Omega Ratio Rank of ANIX is 2626
Omega Ratio Rank
The Calmar Ratio Rank of ANIX is 2828
Calmar Ratio Rank
The Martin Ratio Rank of ANIX is 1919
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Anixa Biosciences, Inc. (ANIX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for ANIX, currently valued at -0.42, compared to the broader market-2.000.002.00-0.421.74
The chart of Sortino ratio for ANIX, currently valued at -0.27, compared to the broader market-4.00-2.000.002.004.006.00-0.272.35
The chart of Omega ratio for ANIX, currently valued at 0.97, compared to the broader market0.501.001.502.000.971.32
The chart of Calmar ratio for ANIX, currently valued at -0.30, compared to the broader market0.002.004.006.00-0.302.61
The chart of Martin ratio for ANIX, currently valued at -1.10, compared to the broader market0.0010.0020.0030.00-1.1010.66
ANIX
^GSPC

The current Anixa Biosciences, Inc. Sharpe ratio is -0.42. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Anixa Biosciences, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.42
1.74
ANIX (Anixa Biosciences, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Anixa Biosciences, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-98.81%
0
ANIX (Anixa Biosciences, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Anixa Biosciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Anixa Biosciences, Inc. was 99.75%, occurring on Aug 15, 2017. The portfolio has not yet recovered.

The current Anixa Biosciences, Inc. drawdown is 98.81%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.75%Jun 14, 19965304Aug 15, 2017
-76.47%Jul 13, 1993292Sep 6, 1994448Jun 13, 1996740
-71.15%Apr 8, 1987148Nov 5, 1987300Jan 13, 1989448
-64.47%Jan 25, 1989400Aug 23, 1990120Feb 13, 1991520
-51.24%May 13, 199160Aug 6, 1991113Jan 16, 1992173

Volatility

Volatility Chart

The current Anixa Biosciences, Inc. volatility is 22.41%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%SeptemberOctoberNovemberDecember2025February
22.41%
3.07%
ANIX (Anixa Biosciences, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Anixa Biosciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Anixa Biosciences, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab